Metabolic Pharmaceuticals (MBP)

Stock Code


Stock Exchange


Metabolic Pharmaceuticals (MBP) is a biotechnology company with around 300 million issued shares. The principal focus of the Company is to take innovative drugs, with strong market potential, through research, formal preclinical and clinical development. MBP developed a drug development platform, for the oral delivery of various injected peptide drugs. This platform offers high potential for use by other companies engaged in the development of peptide drugs together with providing a number of out-licensing opportunities.

Syndicate content

Recommended Websites